Moreover, an NSCLC cell and tissue bioinformatic analysis demonstrated that the MMP-1 gene was overexpressed in erlotinib (a TKI) resistance NSCLC cells through its association with COPS5, which is involved in drug resistance [123]. The gene discussed is MMP1; the disease is non-small cell lung carcinoma.